References
- [1] Dority JS, Oldham JS. Subarachnoid hemorrhage: an update. Anesthesiol Clin 2016;34(3):577–600.
- [2] Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population. JAMA Neurol 2019;Epub ahead of print. doi: 10.1001/jamaneurol.2019.0006.
- [3] Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009;8:635–42.
- [4] Pinnamaneni S, Dutta T, Melcer J, Aronow WS. Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future cardiol 2015;11(1):77–87.
- [5] Guglin M, Novotorova I. Neurogenic stunned myocardium and Takotsubo cardiomyopathy are the same syndrome: a pooled analysis. Congest Heart Fail 2011;17(3):127–32.
- [6] Lee VH, Oh JK, Mulvagh SL, Wijdicks EF. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2006;5(3):243–9.
- [7] Ranieri M, Finsterer J, Bedini G, Parati EA, Bersano A. Takotsubo syndrome: clinical features, pathogenesis, treatment, and relationship with cerebrovascular diseases. Curr Neurol Neurosci Rep 2018;18(5):20.
- [8] Ancona F, Bertoldi LF, Ruggieri F, Cerri M, Magnoni M, Beretta L, Cianflone D, Camici PG. Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different. Eur Heart J 2016;37(37):2830–2.
- [9] Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol 1994;24(3):636–40.
- [10] Norberg E, Odenstedt-Herges H, Rydenhag B, Oras J. Impact of acute cardiac complications after subarachnoid hemorrhage on long-term mortality and cardiovascular events. Neurocrit Care 2018;29(3):404–12.
- [11] Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988–1001.
- [12] Elgendy AY, Elgendy IY, Mansoor H, Mahmoud AN. Clinical presentations and outcomes of Takotsubo syndrome in the setting of of subarachnoid hemorrhage: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2018;7(3):236–45.
- [13] Ropper AH. Acute autonomic emergencies and autonomic storm. In: Low PA, editor. Clinical Autonomic Disorders. Boston: Little, Brown, 1993: 747–60.
- [14] Talman WT. Cardiovascular regulation and lesions of the central nervous system. Ann Neurol 1985;18:1–12.
- [15] Brouwers PJ, Wijdicks EF, Hasan D, Vermeulen M, Wever EF, Frericks H, van Gijn J. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke 1989;20(9):1162–7.
- [16] Talahma N, Alkhachroum AM, Alyahya M, Manjila S, Xiong W. Takotsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: institutional experience and literature review. Clin Neurol Neurosurg 2016;141:65–70.
- [17] Kadooka K, Hadeishi H, Kadooka K. Delayed normalization of electrocardiograms in patients with Takotsubo cardiomyopathy due to aneurysmal subarachnoid hemorrhage. World Neurosurg 2017;100:467–73.
- [18] Kilbourn KJ, Ching G, Silverman DI, McCullough L, Brown RJ. Clinical outcomes after neurogenic stress induced cardiomyopathy in aneurysmal sub-arachnoid hemorrhage: a prospective cohort study. Clin Neurol Neurosurg 2015;128:4–9.
- [19] Kilbourn KJ, Levy S, Staff I, Kureshi I, McCullough L. Clinical characteristics and outcomes of neurogenic stress cardiomyopathy in aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 2013;115(7):909–14.
- [20] Moussouttas M, Mearns E, Walters A, DeCaro M. Plasma catecholamine profile of subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Cerebrovasc Dis Extra 2015;5(2):57–67.
- [21] Doshi R, Neil-Dwyer G. A clinicopathological study of patients following a subarachnoid hemorrhage. J Neurosurg 1980;52:295–301.
- [22] Connor RC. Myocardial damage secondary to brain lesions. Am Heart J 1969;78(2):145–8.
- [23] Ripoll JG, Blackshear JL, Diaz-Gomez JL. Acute cardiac complications in critical brain disease. Neurosurg Clin N Am 2018;29:281–97.
- [24] Karch SB, Billingham ME. Myocardial contraction bands revisited. Am Heart J 1986;17(1):9–13.
- [25] Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86–107.
- [26] Konstantinidis K, Whelan RS, Kitsis RN. Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 2012;32(7):1552–62.
- [27] Masuda T, Sato K, Yamamoto S, Matsuyama N, Shimohama T, Matsunaga A, Obuchi S, Shiba Y, Shimizu S, Izumi T. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 2002;33:1671–6.
- [28] Novitzky D, Wicomb WN, Cooper DKC, Rose AG, Reichart B. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon. Ann Thorac Surg 1986;41(5):520–4.
- [29] Elikowski W, Malek-Elikowska M, Kudlinski B, Skrzywanek P, Smol S, Rzymski S. ECG pattern in reverse Takotsubo cardiomyopathy demonstrated in 5 cases with intracranial hemorrhage. Pol Merkur Lekarski 2016;41(243):136–40.
- [30] Mayer SA, LiMandri G, Sherman D, Lennihan L, Fink ME, Solomon RA, DiTullio M, Klebanoff LM, Beckford AR, Homma S. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg 1995;83(5):889–96.
- [31] Sommargren CE, Zaroff JG, Banki N, Drew BJ. Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J Electrocardiol 2002;35:257–62.
- [32] Chatterjee S. ECG changes in subarachnoid haemorrhage: a synopsis. Neth Heart J 2011;19(1):31–4.
- [33] Ahmadian A, Mizzi A, Banasiak M, Downes K, Camporesi EM, Thompson Sullebarger J, Vasan R, Mangar D, van Loveren HR, Agazzi S. Cardiac manifestations of subarachnoid hemorrhage. Heart Lung Vessel 2013;5(3):168–78.
- [34] Jeong YS, Kim HD. Clinically significant cardiac arrhythmia in patients with aneurysmal subarachnoid hemorrhage. J Cerebrovasc Endovasc Neurosurg 2012;14(2):90–4.
- [35] Andreoli A, di Pasquale G, Pinelli G, Grazi P, Tognetti F, Testa C. Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke 1987;18(3):558–64.
- [36] Frontera JA, Parra A, Shimbo D, Fernandez A, Schmidt JM, Peter P, Claassen J, Wartenberg KE, Rincon F, Badjatia N, Naidech A, Connolly ES, Mayer SA. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis 2008;26(1):71–8.
- [37] Amin H, Aronow WS, Lleva p, McClung JA, Desai H, Gandhi K, Marks S, Singh B. Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Arch Med Sci 2010;6(1):40–2.
- [38] Yolas C, Kanat A, Aydin MD, Altas E, Kanat IF, Kazdal H, Duman A, Gundogdu B, Gursan N. Unraveling of the effect of nodose ganglion degeneration on the coronary artery vasospasm after subarachnoid hemorrhage: an experimental study. World Neurosurg 2016;86:79–87.
- [39] van der Bilt IA, Hasan D, Vandertop WP, Wilde AA, Algra A, Visser FC, Rinkel GJ. Impact of cardiac complications on outcome after subarachnoid hemorrhage: a meta-analysis. Neurology 2009;72(7):635–42.
- [40] Katrukha IA. Human cardiac troponin complex. Structure and functions. Biochemistry (mosc) 2013;78:1447–65.
- [41] Parekh N, Venkatesh B, Cross D, Leditschke A, Atherton J, Miles W et al. Cardiac troponin I predicts myocardial dys-function in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000;36:1328–35.
- [42] Sandhu R, Aronow WS, Rajdev A, Sukhija R, Amin H, D’Aquila K et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol 2008;102(5):632–4.
- [43] Tanabe M, Crago EA, Suffoletto MS, Hravnak M, Frangiskakis JM, Kassam AB. Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol 2008;102(11):1545–50.
- [44] Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005;112:2851–6.
- [45] Oras J, Grivans C, Dalla K, Omerovic E, Rydenhag B, Rick-sten SE et al. High-sensitive troponin T and N-terminal pro B-type natriuretic peptide for early detection of stress-induced cardiomyopathy in patients with subarachnoid hemorrhage. Neurocrit Care 2015;23:233–42.
- [46] M Bay, V Kirk, J Parner, C Hassager, H Nielsen, K Krogsgaard et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003;89(2):150–4.
- [47] Tung PP, Olmsted E, Kopelnik A, Banki NM, Drew BJ, Ko N et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 2005;36:1567–9.
- [48] Banki N, Kopelnik A, Tung P, Lawton MT, Gress D, Drew B et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg 2006;105:15–20.
- [49] Keiko S, Eiichi W, Akira Y, Masatsugu I, Hirotoshi S, Hitoshi H et al. Prognostic implications of left ventricular wall motion abnormalities associated with subarachnoid hemorrhage. Int Heart J 2008;49:75–85.
- [50] Kopelnik A, Fisher L, Miss JC, Banki N, Tung P, Lawton MT et al. Prevalence and implications of diastolic dys-function after subarachnoid hemorrhage. Neurocrit Care 2005;3:132–8.
- [51] Bihorac A, Ozrazgat-Baslanti T, Mahanna E, Malik S, White P, Sorensen M et al. Long-term outcomes for different forms of stress cardiomyopathy after surgical treatment for subarachnoid hemorrhage. Anesth Analg 2016;122:1594–602.
- [52] Diringer MN, Bleck TP, Claude Hemphill J, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 2011;15:211–40.
- [53] Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasad A. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart 2009;95:1436–41.
- [54] Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 2015;373:929–38.
- [55] Citro R, Rigo F, D’Andrea A, Ciampi Q, Parodi G, Provenza G, et al. Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. JACC Cardiovasc Imaging 2014;7:119–29.
- [56] Kerro A, Woods T, Chang JJ. Neurogenic stunned myocardium in subarachnoid hemorrhage. J Crit Care 2017;38:27–34.
- [57] Malik AN, Gross BA, Rosalind Lai PM, Moses ZB, Du R. Neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. World Neurosurg 2015;83:880–5.
- [58] Mazzeo AT, Micalizzi A, Mascia L, Scicolone A, Siracusano L. Brain–heart crosstalk: the many faces of stress-related cardiomyopathy syndromes in anaesthesia and intensive care. Br J Anaesth 2014;112:803–15.
- [59] Cruickshank JM, Neil-Dwyer G, Hayes Y, Degaute JP, Kuurne T, Kytta J, et al. Stress/catecholamine-induced cardiac necrosis. Reduction by beta 1-selective blockade. Postgrad Med 1988;Spec No:140–7.
- [60] Liang CW, Chen R, Macri E, Naval N. Preadmission beta-blockers are associated with decreased incidence of neurogenic stunned myocardium in aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2013;22:601–7.
- [61] Cereda C, Ghika J, Maeder P, Bogousslavsky J. Strokes restricted to the insular cortex. Neurology 2002;59:1950–5.
- [62] Kumar S, Kaushik S, Nautiyal A, Choudhary SK, Kayastha BL, Mostow N, et al. Cardiac rupture in Takotsubo cardiomyopathy: a systematic review. Clin Cardiol 2011;34:672–6.
- [63] Vriz O, Brosolo G, Martina S, Pertoldi F, Citro R, Mos L, et al. In-hospital and long-term mortality in Takotsubo cardiomyopathy: a community hospital experience. J Community Hosp Intern Med Perspect 2016;6:31082.
- [64] Taccone FS, Brasseur A, Vincent J-L, De Backer D. Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock. Intensive Care Med 2013;39:1497–8.
- [65] Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007;50:448–52.
- [66] Al-Mufti F, Morris N, Lahiri S, Roth W, Witsch J, Machado I, et al. Use of intra-aortic-balloon pump counterpulsation in patients with symptomatic vasospasm following subarachnoid hemorrhage and neurogenic stress cardiomyopathy. J Vasc Interv Neurol 2016;9:28–34.
- [67] Gopinath R, Ayya S. Neurogenic stress cardiomyopathy: what do we need to know. Ann Card Anaesth 2018;21:228.
- [68] Vriz O, Brosolo G, Martina S, Pertoldi F, Citro R, Mos L et al. In-hospital and long-term mortality in Takotsubo cardiomyopathy: a community hospital experience. J Community Hosp Intern Med Perspect 2016;6(3).
- [69] Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD, Wijdicks EFM. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 2006;105:264–70.
- [70] Song BG, Park S-J, Noh HJ, Jo HC, Choi J-O, Lee S-C, et al. Clinical characteristics, and laboratory and echocardiographic findings in Takotsubo cardiomyopathy presenting as cardiogenic shock. J Crit Care 2010;25:329–35.